MedPath
HSA Approval

APO-LORAZEPAM TABLET 0.5 mg

SIN03708P

APO-LORAZEPAM TABLET 0.5 mg

APO-LORAZEPAM TABLET 0.5 mg

October 6, 1989

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05BA06

lorazepam

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

LORAZEPAM

0.5 mg

Lorazepam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-LORAZEPAM TABLET 0.5 mg - HSA Approval | MedPath